Webinar Long Acting Injectable Antipsychotics in Practice

Long-acting injectable (LAI) antipsychotic formulations are being considered more often in the treatment of schizophrenia to promote medication adherence. Genoa Healthcare recently hosted a webinar providing an update on available LAIs and addressing potential reasons for starting patients on the medications. Can Genoa help your clinic and consumers with LAIs?

[@jessicajoy6280]

LAI and patients with diagnosis of Parkinson’s Disease and taking Carbidlevodopa?

[@debralavigne6563]

How do I get my pills out

[@jessicajoy6280]

How about Parkinson’s psychosis and how patients can become psychotic due to interactions due to antipsychotic….